Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biomerk

2006 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of pre-clinical platform for tumor cancer. The company engages in generating preclinical platform of human cancer tumor immune-deficient mice xenografts namely Biomerk Tumorgrafts.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 15111 North Hayden Road
  • Suite 160
  • Scottsdale, AZ 85260
  • United States

Biomerk Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Biomerk‘s full profile, request access.

Request full access to PitchBook

Biomerk Executive Team (1)

Name Title Board
Seat
Contact
Info
David Sidransky MD Founder